glp 1 in australia Scam weight-loss drops marketed to Australians contain 'basically salty water', analysis finds | Scams Australia GLP-1 Receptor Agonist Market
Description
The second developed approach, body roundness index (BRI), associates a persons shape phenotype with high-risk adiposity components and multiple health outcomes
Eli Lilly makes the best-selling GLP-1 drug, and sales are accelerating.
How many people take GLP-1 medications
When branded therapies of semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound) commanded high prices and faced prolonged shortages from late 2022 through early 2025, compounding pharmacies emerged as alternative providers offering lower-cost formulations
Numerous analysts have said the GLP-1s are very likely to disrupt certain areas of the MedTech industry, while others say MedTech can live side-by-side with the weight-loss drugs.1 In fact, the impact of GLP-1s is likely to be more nuanced than the blunt conclusions drawn by market watchers, with some companies and segments affected more than others
Learn the facts about GLP-1 side effects, how they differ from SGLT2s, and tips for prevention
